Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

NCT00102752 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Pancreatic Neoplasms

Interventions

DRUG: Glufosfamide
DRUG: Gemcitabine

Sponsor

Threshold Pharmaceuticals

Collaborators

[object Object]